Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies

Clinical trial NCT01260545 · COMPLETED

Trial details

NCT number: NCT01260545
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2011-04-30
Primary completion: 2012-06-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.